FDA Moves to Classify 7-OH: A Dangerous Opioid in Disguise

The FDA is advocating for 7-OH to be classified as a controlled substance due to its opioid-like properties. This compound, often found in vape products and edibles, poses abuse risks. The FDA plans to inform the DEA and alert physicians nationwide about 7-OH’s potential dangers.

The U.S. Food and Drug Administration (FDA) is calling for the classification of the 7-OH compound as a controlled substance, citing its opioid properties, FDA Commissioner Marty Makary announced Tuesday.

This compound is widely available in vape stores, drinks, and even children's gummies, said Makary during a press briefing. The FDA acknowledged the increasing abuse potential of 7-OH, due to its ability to bind to opioid receptors. As a preventive action, the FDA is sending a formal letter to the Drug Enforcement Administration, recommending the scheduling of 7-OH above a specific concentration as a Class 1 controlled substance.

Despite its serious risks, 7-OH can be readily purchased from smoke shops, convenience stores, and gas stations across the U.S., Commissioner Makary warned. To combat this growing issue, the FDA will issue a report detailing the risks of 7-OH, a synthetic derivative of the kratom plant, and circulate a warning letter to physicians nationwide. "We're going to continue to try to educate the public," Makary emphasized.

(With inputs from agencies.)